Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.8300 (12.47%) ($9.8300 - $9.8300) on Fri. May. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.93% (three month average) | RSI | 66 | Latest Price | $9.8300(12.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 4% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(50%) IWC(50%) IWO(46%) IWM(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.465% in a week (0% probabilities). SMH(-17%) IGOV(-15%) VXX(-8%) VIXM(-8%) UUP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.465% (StdDev 4.93%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.61(14.17%) | 10 Day Moving Average | $8.3(18.43%) | 20 Day Moving Average | $7.93(23.96%) | To recent high | -12.3% | To recent low | 54.7% | Market Cap | $610m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |